Related Experiment Videos
Practical management of diabetes during Ramadan fasting
M Fariduddin1, H Mahtab, Z A Latif
1Department of Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Mymensingh Medical Journal : MMJ
|August 2, 2011
Summary
Most type-2 diabetes patients can safely fast during Ramadan with pre-fasting counseling. This involves assessment, education, and adjustments to diet and medication to manage risks and ensure safe Ramadan fasting.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Islamic Studies
Background:
- Diabetes mellitus is a growing global epidemic, posing significant health and economic burdens.
- Fasting during Ramadan is a core Islamic practice, with increasing numbers of type-2 diabetes patients participating.
- Managing diabetes during Ramadan requires careful consideration of potential health benefits and risks.
Purpose of the Study:
- To assess the safety and benefits of Ramadan fasting for type-2 diabetes patients.
- To highlight the importance of pre-Ramadan counseling for diabetes management.
- To outline strategies for minimizing risks associated with fasting.
Main Methods:
- Review of recent studies on type-2 diabetes management during Ramadan.
- Emphasis on pre-Ramadan counseling including assessment, education, motivation, and adjustments in diet and medication.
- Individualized management plans and close monitoring during fasting.
Main Results:
- Most type-2 diabetes patients can fast safely with proper preparation.
- Fasting can improve metabolic control, aid weight reduction, and help manage hypertension.
- Potential risks include hypoglycemia, diabetic ketoacidosis, hyperosmolar non-ketotic coma, and dehydration, which can be mitigated by counseling.
Conclusions:
- Pre-Ramadan counseling is crucial for safe and effective diabetes management during fasting.
- Individualized plans and close monitoring are essential to prevent complications.
- Patients at very high risk should not fast, and fasting should be broken if hypoglycemia occurs.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...